Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others. It is also used to prevent worsening of asthma and chronic obstructive pulmonary disease (COPD). It can be taken in various ways including by mouth, injection into a muscle, and inhalation.
Community, Culture, Applications & Standards
Explore the main themes, entities and connections around Triamcinolone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
effects side include use due risk action well blood concentrations also infections used muscle glucocorticoid osteoporosis inflammation plasma medical drugs
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Triamcinolone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Triamcinolone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Triamcinolone | ATC code | A01AC01 (WHO) C05AA12 (WHO), D07AB09 (WHO), H02AB08 (WHO), R01AD11 (WHO), R03BA06 (WHO), S01BA05 (WHO) | 1.00 | infobox |
| Triamcinolone | Bioavailability | >90% | 1.00 | infobox |
| Triamcinolone | CAS Number | 124-94-7 Y | 1.00 | infobox |
| Triamcinolone | ChEBI | CHEBI:9667 N | 1.00 | infobox |
| Triamcinolone | ChEMBL | ChEMBL1451 Y | 1.00 | infobox |
| Triamcinolone | ChemSpider | 29046 Y | 1.00 | infobox |
| Triamcinolone | CompTox Dashboard (EPA) | DTXSID1040742 | 1.00 | infobox |
| Triamcinolone | DrugBank | DB00620 Y | 1.00 | infobox |
| Triamcinolone | ECHA InfoCard | 100.004.290 | 1.00 | infobox |
| Triamcinolone | Elimination half-life | 200–300 minutes (plasma), up to 36 hours (total) | 1.00 | infobox |
| Triamcinolone | Excretion | Urine (75%) and faeces (25%) | 1.00 | infobox |
| Triamcinolone | Formula | C21H27FO6 | 1.00 | infobox |
| Triamcinolone | IUPHAR/BPS | 2870 | 1.00 | infobox |
| Triamcinolone | KEGG | D00385 Y | 1.00 | infobox |
| Triamcinolone | Legal status | AU: S4 (Prescription only) / S3 | 1.00 | infobox |
| Triamcinolone | Legal status | UK: POM (Prescription only) / P | 1.00 | infobox |
| Triamcinolone | Legal status | US: ℞-only / OTC (Nasacort, intranasal) | 1.00 | infobox |
| Triamcinolone | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Triamcinolone | License data | US DailyMed: Triamcinolone | 1.00 | infobox |
| Triamcinolone | MedlinePlus | a601122 | 1.00 | infobox |
| Triamcinolone | Melting point | 260 to 271 °C (500 to 520 °F) | 1.00 | infobox |
| Triamcinolone | Metabolism | Liver | 1.00 | infobox |
| Triamcinolone | Molar mass | 394.439 g·mol−1 | 1.00 | infobox |
| Triamcinolone | Onset of action | (2–)24(–48) hours | 1.00 | infobox |
| Triamcinolone | Other names | .mw-parser-output .hidden-begin{box-sizing:border-box;width:100%;padding:5px;border:none;font-size:95%}.mw-parser-output .hidden-title{font-weight:bold;line-height:1.6;text-alig… | 1.00 | infobox |
| Triamcinolone | Pregnancy category | AU: A | 1.00 | infobox |
| Triamcinolone | Protein binding | 68%[citation needed] | 1.00 | infobox |
| Triamcinolone | PubChem CID | 31307 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.